J M Essigmann|W F Busby|G N Wogan - JoVE Visualize

Showing results (101-110 of 194) with videos related to

Pageof 20

Sort By:

Biochemistry|November 18, 1998

Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factorX Zhai, H Beckmann, H M Jantzen, et al.

The Journal of Biological Chemistry|February 15, 1991

Relative efficiencies of the bacterial, yeast, and human DNA methyltransferases for the repair of O6-methylguanine and O4-methylthymine. Suggestive evidence for O4-methylthymine repair by eukaryotic methyltransferasesM Sassanfar, M K Dosanjh, J M Essigmann, et al.

Biochemistry|July 31, 1990

Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genomeM L Wood, M Dizdaroglu, E Gajewski, et al.

Chemistry & Biology|July 1, 1996

The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatinJ A Mello, S Acharya, R Fishel, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990

Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumorsG McMahon, E F Davis, L J Huber, et al.

Biochemistry|September 11, 1990

Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replicationW J Heiger-Bernays, J M Essigmann, S J Lippard

Cancer Research|May 15, 1997

Nitrotyrosine formation, apoptosis, and oxidative damage: relationships to nitric oxide production in SJL mice bearing the RcsX tumorA Gal, S Tamir, L J Kennedy, et al.

Carcinogenesis|June 1, 1986

In vitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2-deoxyguanosine adductJ R Babson, S E Russo-Rodriguez, W H Rastetter, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994

Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor)D K Treiber, X Zhai, H M Jantzen, et al.

Mutation Research|March 1, 1995

Mutagenicity of benzo[a]pyrene and dibenzopyrenes in the Salmonella typhimurium TM677 and the MCL-5 human cell forward mutation assaysW F Busby, H Smith, C L Crespi, et al.

Pageof 20

Showing results (101-110 of 194) with videos related to

Sort By:

Pageof 20

Biochemistry|November 18, 1998

Cisplatin-DNA adducts inhibit ribosomal RNA synthesis by hijacking the transcription factor human upstream binding factorX Zhai, H Beckmann, H M Jantzen, et al.

The Journal of Biological Chemistry|February 15, 1991

Relative efficiencies of the bacterial, yeast, and human DNA methyltransferases for the repair of O6-methylguanine and O4-methylthymine. Suggestive evidence for O4-methylthymine repair by eukaryotic methyltransferasesM Sassanfar, M K Dosanjh, J M Essigmann, et al.

Biochemistry|July 31, 1990

Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genomeM L Wood, M Dizdaroglu, E Gajewski, et al.

Chemistry & Biology|July 1, 1996

The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatinJ A Mello, S Acharya, R Fishel, et al.

Proceedings of the National Academy of Sciences of the United States of America|February 1, 1990

Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumorsG McMahon, E F Davis, L J Huber, et al.

Biochemistry|September 11, 1990

Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replicationW J Heiger-Bernays, J M Essigmann, S J Lippard

Cancer Research|May 15, 1997

Nitrotyrosine formation, apoptosis, and oxidative damage: relationships to nitric oxide production in SJL mice bearing the RcsX tumorA Gal, S Tamir, L J Kennedy, et al.

Carcinogenesis|June 1, 1986

In vitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2-deoxyguanosine adductJ R Babson, S E Russo-Rodriguez, W H Rastetter, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994

Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor)D K Treiber, X Zhai, H M Jantzen, et al.

Mutation Research|March 1, 1995

Mutagenicity of benzo[a]pyrene and dibenzopyrenes in the Salmonella typhimurium TM677 and the MCL-5 human cell forward mutation assaysW F Busby, H Smith, C L Crespi, et al.

Pageof 20